SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Robinson JW, Dufour Ms, Fung TS. Erectile functioning of men treated for prostate carcinoma. Cancer. 1997; 79: 538544.
  • 2
    Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 2000; 55: 5861.
  • 3
    Fossa SD, Woehre H, Kurth KH, et al. Influence of urological morbidity on quality of life in patients with prostate cancer. Eur Urol. 1997; 31 (Suppl 3): S3S8.
  • 4
    Bates TS, Wright MP, Gillatt DA. Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire. Eur Urol. 1998; 33: 165169.
  • 5
    Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol. 1996; 14: 22582265.
  • 6
    Gaylis FD, Friedel WE, Armas OA. Radical retropubic prostatectomy outcomes at a community hospital. J Urol. 1998; 159: 167171.
  • 7
    Schrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer. 1997; 79: 19771986.
  • 8
    Smith DS, Carvalhal GF, Schneider K, Drygiel J, Yan Y, Catalona WJ. Quality-of-life outcomes for men with prostate carcinoma detected by screening. Cancer. 2000; 88: 14541463.
  • 9
    Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000; 283: 354360.
  • 10
    Talcott JA, Rieker P, Propert KJ, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst. 1997; 89: 11171123.
  • 11
    Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 2000; 163: 851857.
  • 12
    Beard CJ, Propert KJ, Rieker PP, et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol. 1997; 15: 223229.
  • 13
    Mantz CA, Song P, Farhangi E, et al. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997; 37: 551557.
  • 14
    Roach M, Chinn DM, Holland J, Clarke M. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1996; 35: 869874.
  • 15
    Wilder RB, Chou RH, Ryu JK, et al. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results. Am J Clin Oncol. 2000; 23: 330333.
  • 16
    Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for early prostate cancer. JAMA. 1995; 273: 122134.
  • 17
    Talcott JA, Rieker P, Clark JA, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol. 1998; 16: 275283.
  • 18
    Helgason AR, Adolfsson J, Dickman P, Arver S, Fredrikson M, Steineck G. Factors associated with waning sexual function among elderly men and prostate cancer patients. J Urol. 1997; 158: 1551559.
  • 19
    Merrick GS, Butler WM, Galbreath RW, et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2002; 52: 893902.
  • 20
    Potosky AL, Reeve BB, Clegg LX, et al. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst. 2002; 94: 430437.
  • 21
    Schroder FH, Collette L, de Reijke TM, Whelan P. Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. Br J Cancer. 2000; 82: 283290.
  • 22
    Karakiewicz PL, Aprikian AG, Bazinet M, Elhilali MM. Patient attitudes regarding treatment-related ED at the time of early detection of prostate cancer. Urology. 1997; 50: 704709.
  • 23
    Fowler FJ Jr., Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology. 1995; 45: 10071013.
  • 24
    Andersen BL, Cyranowski JM, Espindle D. Men's sexual self-schema. J Personality Soc Psychol. 1999; 76: 645661.
  • 25
    Andersen BL, Woods XA, Copeland LJ. Sexual self-schema and sexual morbidity among gynecologic cancer survivors. J Consult Clin Psychol. 1997; 65: 221229.
  • 26
    Andersen BL. Surviving cancer: the importance of sexual self-concept. Med Pediatr Oncol. 1999; 33: 1523.
  • 27
    Rosen RC, Riley A, Wagner G, Osterloh IA, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49: 822830.
  • 28
    Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998; 36: 10021012.
  • 29
    Ware JE Jr. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, 1993.
  • 30
    Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Int Med. 1998; 13: 159166.
  • 31
    Litwin MS, McGuigan KA. Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. J Clin Oncol. 1999; 17: 28822888.
  • 32
    Legler J, Potosky AL, Gilliland FD, Eley JW, Stanford JL. Validation study of retrospective recall of disease-targeted function: results from the Prostate Cancer Outcomes Study. Med Care. 2000; 38: 847857.
  • 33
    Cappelleri JC, Siegel RL, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile function and the erectile function domain of the International Index of Erectile Function. Urol. 2000; 56: 477481.
  • 34
    Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston: The Health Institute, 1994.
  • 35
    Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Quality of Life Res. 2001; 10: 405413.
  • 36
    Shahidi M, Norman AR, Gadd J, Huddart RA, Horwich A, Dearnaley DP. Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer. Clin Oncol. 2001; 13: 291295.
  • 37
    Mantz CA, Nautiyal J, Awan A, et al. Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors. Cancer J Sci Am. 1999; 5: 230536.
  • 38
    Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001; 50: 12351242.
  • 39
    Zelefsky MJ, Cowen D, Fuks Z, et al. Long-term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 1999; 85: 24602468.
  • 40
    Hart KB, Duclos M, Shamsa F, Forman JD. Potency following conformal neutron/photon irradiation for localized prostate cancer. Int J Radiat Oncol Biol Phys. 1996; 35: 881884.
  • 41
    Sanchez-Ortiz RF, Broderick GA, Rovner ES, Wein AJ, Whittington R, Malkowicz SB. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impotence Res. 2000; 12 (Suppl 3): S18S24.
  • 42
    Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J Clin Oncol. 1998; 16: 501514.
  • 43
    Schover LR, Yetman RJ, Tuason LJ, et al. Partial mastectomy and breast reconstruction: a comparison of their effects on psychosocial adjustment, body image, and sexuality. Cancer. 1995; 75: 5464.
  • 44
    Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999; 14: 537546.
  • 45
    Laumann EO, Gagnon JH, Michael RT, Michaels S. The social organization of sexuality: sexual practices in the United States. Chicago: University of Chicago Press, 1994: 518529.
  • 46
    Incrocci L, Koper PCM, Hop WCJ, Slob AK. Sildenafil citrate (Viagra) and erectile dysfunction following external beam radiotherapy for prostate cancer: a randomized, double-blind, placebo-controlled, cross-over study. Int J Radiat Oncol Biol Phys. 2001; 51: 11901195.
  • 47
    Lowentritt BH, Scardino PT, Miles BJ, et al. Sildenafil citrate after radical retropubic prostatectomy. J Urol. 1999; 1625: 16141622.
  • 48
    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1991; 151: 5461.
  • 49
    Au DH, McDonnel M, Martin DC, Fihn SD. Regional variations in health status. Med Care. 2001; 39: 879888.
  • 50
    Wensing M, Vingerhoets E, Grol R. Functional status, health problems, age and comorbidity in primary care patients. Quality of Life Res. 2001; 10: 141148.
  • 51
    Bacon CG, Giovannucci E, Testa M, Glass TA, Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer. 2002; 94: 862871.